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Purpose: Obesity is a major risk factor for asthma and it
influences airway smooth muscle function and responsiveness.
Adiponectin is inversely associated with obesity and its action
is mediated through at least 2 cell membrane receptors
(AdipoR1 and AdipoR2). Leptin is positively associated with
obesity. We investigated whether human airway smooth
muscle (ASM) cells express adiponectin receptors and whether
adiponectin and leptin regulate human ASM cell proliferation
and vascular endothelial growth factor (VEGF) release.
Materials and Methods: Human ASM cells were growth-
arrested in serum-deprived medium for 48 hours and then
stimulated with PDGF, adiponectin and leptin. After 48 hours
of stimulation, proliferation was determined using a cell
proliferation ELISA kit. Human AdipoR1 and -R2 mRNA
expressions were determined by RT-PCR using human-
specific AdipoR1 and -R2 primers. Concentrations of VEGF,
monocyte chemotactic protein (MCP)-1 and macrophage in-
flammatory protein (MIP)-1 in cell culture supernatant were ɑ
determined by ELISA. Results: Both AdipoR1 and AdipoR2
mRNA were expressed in the cultured human ASM cells.
However, adiponectin did not suppress PDGF-enhanced ASM
cell proliferation, nor did leptin promote ASM cell prolifera-
tion. Leptin promoted VEGF release by human ASM cells,
while adiponectin did not influence VEGF release. Neither
leptin nor adiponectin influenced MCP-1 secretion from
human ASM cells. Adiponectin and MIP-1 were not secreted ɑ
by human ASM cells. Conclusion: Human ASM cells expressed
adiponectin receptors. However, adiponectin did not regulate
human ASM cell proliferation or VEGF release, while leptin
stimulated VEGF release by human ASM cells.
Key Words: Smooth muscle cells, cell proliferation, vascular
endothelial growth factor, leptin, adiponectin, receptors
INTRODUCTION
Obesity has become a major health problem
worldwide and its incidence has sharply increased.
Prevalence of asthma has also been steadily
increasing during the past 30 years. Obesity is a
major risk factor for asthma, and it increases the
prevalence and severity of asthma and also
influences lung function. Girls who become obese
between the ages of 6 and 11 years have an almost
fivefold increased risk of developing new asthma
symptoms.
1 Weight loss reduces airway obstruc-
tion as well as peak expiratory flow variability in
obese patients with asthma.
2 Studies on mice have
shown a causal relationship between obesity and
asthma.
3 Obesity influences airway smooth muscle
function and airway hyper-responsiveness (AHR).
In epidemiological studies, the body mass index
(BMI) has been shown to be associated with
AHR,
4 and innate AHR is manifested in obese
mice.
5
Hyperplasia and hypertrophy of airway smooth
muscle (ASM) are characteristic features of airway
remodeling in asthma. There is limited informa-
tion on how obesity influences smooth muscle
function. Obesity may reduce lung growth in
childhood, which leads to reduced functional
residual capacity, and may accelerate airway
remodeling when asthma is exacerbated.
6 Obesity
induces systemic inflammation, which can affect
the lung microenvironment by circulating cytokines
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and chemokines. Adiponectin, a fat tissue-derived
hormone, is inversely associated with obesity. In
children with obesity, serum adiponectin levels
decrease,
7 and adiponectin mRNA expression from
adipose tissue is negatively associated with
obesity.
8 Adiponectin also demonstrates anti-
inflammatory effects and down-regulation of
vascular smooth muscle cell proliferation.
9 The
activity of adiponectin is mediated by at least 2
cell membrane receptors (AdipoR1 and AdipoR2).
However, there has been no report to date, on
identification of adiponectin receptors in human
ASM cells.
Leptin is a 16-kDa peptide released from fat
cells and other tissues, and may exacerbate airway
inflammation in asthma. It induces pulmonary
inflammation after ozone exposure in mice,
5 and
augments AHR in ovalbumin-sensitized mice.
3
Leptin induces cytokine production and cell
proliferation in hematopoietic cells
10 and human
umbilical vein endothelial cells.
11 However, it is
unknown whether leptin influences ASM cell pro-
liferation and cytokine production by ASM cells.
The goal of this study was to identify adipo-
nectin receptors (AdipoR1 and AdipoR2) in human
ASM cells and evaluate whether adiponectin and
leptin regulate ASM cell proliferation. On the
basis of the above, we hypothesized that leptin
would enhance ASM cell proliferation, compared
to no stimulation, and adiponectin would inhibit
ASM cell proliferation enhanced by PDGF
stimulation. In addition, we investigated whether
adiponectin and leptin influence the release of
vascular endothelial growth factor (VEGF),
monocyte chemotactic protein (MCP)-1, macro-
phage inflammatory protein (MIP)-1 , and ɑ
adiponectin from ASM cells.
MATERIALS AND METHODS
Human airway smooth muscle cell culture
Primary human ASM cells and cell growth
supplements were purchased from Clonetics (San
Diego, CA, USA). Penicillin, streptomycin, fetal
bovine serum (FBS), 10% Dulbecco's modified
Eagle's medium (DMEM), and DMEM/F-12 medi-
um were obtained from Gibco BRL. Bovine serum
albumin (BSA) and insulin-transferrin-selenium
(ITS) were obtained from Sigma. Adiponectin,
leptin and PDGF were purchased from R & D (R
& D Systems, Minneapolis, MN, USA).
Human ASM cells were plated in 75 cm
2 culture
flasks with 10% FBS/DMEM containing 100 IU/
mL penicillin, 100 g/mL streptomycin, and 2 μ mM
L-glutamine, and were incubated in a humidified
incubator at 37°C with 5% CO2. When the cells
became confluent, they were passaged with the
use of 0.025% trypsin in 0.01% EDTA. Cells at
passages 3 to 6 were used for all experiments.
Analysis of human ASM cell proliferation
Human ASM cells were seeded at a density of
1 × 10
4 cells/cm
2 in 96-well culture plates. When
the cells reached 70% confluence, growth was
arrested in serum-free DMEM/F-12 medium
containing 0.1% BSA for 48 hours. Cells were then
incubated with 20 ng/mL of platelet-derived
growth factor (PDGF) for 48 hours as a positive
control. ASM cell proliferations were compared
after stimulation with 10, 50 and 100 ng/mL of
leptin, and 10, 50, and 100 ng/mL of adiponectin
with and without PDGF co-stimulation.
Cell proliferation was measured using a
bromodeoxyuridine (BrdU) cell proliferation
ELISA kit (Roche Applied Science, Mannheim,
Germany). The cells were cultured in 96-well
plates under the same conditions as described
above and incubated with 10 M BrdU for 24 μ
hours. The BrdU incorporation into DNA was
detected using a commercial kit. Briefly, cells
were fixed and DNA was denatured. Anti-BrdU-
POD monoclonal antibody was used to bind to
the BrdU incorporated into the newly synthesized
cellular DNA. The absorbance of immune com-
plex was measured at 450 nm.
Preparation of RNA and reverse transcriptase-
polymerase chain reaction (RT-PCR) for
adiponectin receptors
The total cellular RNA was prepared using a
Trizol reagent kit. After quantification by spectro-
photometry, the RNA was reverse transcribed and
cDNAs were produced. PCR was performed in a
Takara PCR thermal cycler at a 50 L reaction μJoo Hwa Shin, et al.
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volume containing 100 ng of genomic DNA, 10
mM Tris HCl, 50 mM KCl, 1.5 mM MgCl2, 0.08%
Triton X-100, 200 M deoxyribonucleotides, 0.75 U μ
Taq polymerase, and 1.0 M oligonucleotide μ
primers of each gene. The following primers were
used: for human AdipoR1, the forward primer
was 5’-TTCTTCCTCATGGCTGTGATGT-3’, reverse:
5’-AAGAAGCGCTCAGGAATTCG-3’ (GenBank
accession number: NM015999); for human Adipo
R2, the forward primer was 5’-ATAGGGCAGAT
AGGCTGGTTGA-3’, and the reverse primer was
5’-GGATCCGGGCAGCATACA-3’ (GenBank acces-
sion number: nm024551); for -actin, the forward β
primer was 5’-GATCTTGATCTTCATGGTGCTAG
G-3’, and the reverse primer was 5’-TTGTAACCA
ACTGGGACCATATGG-3’ (GenBank accession
number: AL451010).
12,13 After the initial denatura-
tion at 95°C for 5 minutes, 40 cycles of denaturation
for 1 minute at 95°C, annealing for 1 minute at
55°C and extension for 1 minute at 72°C were
carried out, and the PCR was terminated by a
final extension at 72°C for 10 minutes. Reaction
products were then separated on a 1% agarose gel
in Tris acetate EDTA buffer. Sequence of the PCR
products was confirmed by the National Center
for Biotechnology Information (NCBI) nucleotide-
nucleotide BLAST program.
Cytokine assay
To evaluate the effects of adiponectin and leptin
on the production of VEGF, MCP-1 and MIP-1 , ɑ
by human ASM cells, the cells were cultured to
confluence in 10% FCS/DMEM in humidified 5%
CO2 air at 37°C in 24-well culture plates and
growth-arrested in serum-free DMEM/F-12
medium for 48 hours. Cells were stimulated with
20 ng/mL of PDGF, 10, 50, and 100 ng/mL of
leptin and 10, 50, and 100 ng/mL of adiponectin.
After 24-hours of incubation, the cell culture
supernatant was harvested and stored at - 80°C
until ELISA for cytokines was performed.
Measurement of VEGF, MCP-1 and MIP-1 by ELISA ɑ
VEGF, MCP-1 and MIP-1 in cell culture super ɑ -
natants were analyzed by ELISA according to the
manufacture's manuals (R & D Systems). The
minimum detectable doses of cytokines were less
than 5 pg/mL for VEGF and MCP-1 and less than
10 pg/mL for MIP-1 . ɑ
Statistics
Each experiment was repeated on multiple
occasions with triplicate dishes. Data were
evaluated by one-way ANOVA followed by the
Bonferroni's multiple comparison test.
RESULTS
Expression of AdipoR1 and AdipoR2 mRNA on
the human ASM cells
We found that the mRNAs of adiponectin
receptors 1 and 2 were expressed in cultured
human ASM cells. Sequencing of PCR products
demonstrated that results were compatible with
human adiponectin receptors 1 and 2 (according
to the NCBI nucleotide-nucleotide BLAST pro-
gram), thus confirming the presence of these
genes in human ASM cells (Fig. 1).
Effect of adiponectin and leptin on the prolifera-
tion of human ASM cells
To evaluate the effect of leptin on human ASM
cell proliferation, ASM cells were stimulated with
leptin (10, 50, and 100 ng/mL) and 20 ng/mL of
Fig. 1. Expression of adiponectin receptors AdipoR1 and
AdipoR2 in the human airway smooth muscle cell.
Expression of -actin (lane 1), AdipoR1 (lane 2) and β
AdipoR2 (lane 3) mRNA is observed. Sequencing of these
PCR products demonstrated that the products were
compatible with human AdipoR1 and AdipoR2
(according to NCBI nucleotide-nucleotide BLAST); these
findings confirmed the presence of these genes in the
human airway smooth muscle cells.Adiponectin and Leptin on Smooth Muscle Cells
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PDGF, and the proliferation was then compared
with unstimulated ASM cells. The stimulation
with PDGF significantly enhanced ASM cell
proliferation compared to control cells. However,
leptin did not enhance nor suppress ASM cell
proliferation at all concentrations studied (Fig. 2).
Leptin also did not augment PDGF-enhanced
ASM cell proliferation when co-stimulated with
PDGF (data not shown).
Since the serum adiponectin level is inversely
correlated with obesity, we investigated whether
adiponectin had any effect on down-regulation of
PDGF-enhanced ASM cell proliferation. Thus,
human ASM cells were stimulated with 20
ng/mL of PDGF with and without adiponectin
(10, 50, and 100 ng/mL), and the proliferation was
compared to cells stimulated with PDGF only.
The PDGF-stimulated ASM cells showed enhanced
proliferation. However, adiponectin did not
suppress PDGF-enhanced ASM cell proliferation
at all doses studied (Fig. 3). We also stimulated
ASM cells with adiponectin only, however, no
difference in proliferation was observed com-
pared to no stimulation (data not shown).
Effect of PDGF, adiponectin and leptin on VEGF
release by human ASM cells
Human ASM cells were treated with PDGF (20
ng/mL), adiponectin (50 ng/mL), and leptin (50
ng/mL). VEGF release was significantly enhanced
by both PDGF and leptin stimulation compared
to controls. VEGF release by leptin stimulation
was higher than PDGF stimulation. However,
adiponectin did not show any additive effects on
VEGF release when added to leptin. Adiponectin
did not suppress PDGF-enhanced VEGF release
nor did VEGF release by unstimulated ASM cells
(Fig. 4).
Fig. 2. Effect of leptin on the proliferation of human ASM
cells. Human ASM cells were stimulated with leptin (10,
50 and 100 ng/mL) and 20 ng/mL of PDGF, and com-
pared to unstimulated cells. Leptin did not enhance or
suppress ASM cell proliferation, while PDGF significantly
augmented cell stimulation. ASM, airway smooth muscle;
PDGF, platelet-derived growth factor. *p < 0.01 vs. Control.
Fig. 4. Effect of PDGF, adiponectin and leptin on VEGF
release by human ASM cells. Human ASM cells were
treated with 20 ng/mL of PDGF, 50 ng/mL of adipo-
nectin and 50 ng/mL of leptin. VEGF release was
significantly enhanced by PDGF stimulation compared to
no stimulation. Leptin significantly augmented VEGF
release compared to no stimulation or stimulation by
PDGF. Adiponectin showed no stimulatory or inhibitory
effects on VEGF release, when it stimulated cells with
and without PDGF or leptin. PDGF, platelet-derived
growth factor; VEGF, vascular endothelial growth factor.
*p < 0.05 vs. Control, **p < 0.05 vs. Control and PDGF.
Fig. 3. Effect of adiponectin on the proliferation of human
ASM cells. Human ASM cells were stimulated with 20
ng/mL of PDGF in the presence or absence of adipo-
nectin (10, 50, and 100 ng/mL), and proliferation was
compared with the control. PDGF-stimulated ASM cells
showed enhanced proliferation, however, adiponectin did
not enhance or suppress PDGF-enhanced ASM cell
proliferation. ASM, airway smooth muscle; PDGF,
platelet-derived growth factor. *p < 0.01 vs. Control.Joo Hwa Shin, et al.
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Effect of PDGF, adiponectin and leptin on MCP-1,
MIP-1 and adiponectin releases by human ASM ɑ
cells
We evaluated the release of MCP-1 by human
ASM cells treated with PDGF, adiponectin and
leptin. MCP-1 was released by ASM cells, but was
neither augmented, nor suppressed by PDGF,
leptin or adiponectin stimulation. There were no
differences in MCP-1 release when it was co-
stimulated with adiponectin and leptin or with
adiponectin and PDGF (Fig. 5). Human ASM cells
did not secrete MIP-1 or adiponectin after ɑ
stimulation with PDGF, leptin or adiponectin
(data not shown).
DISCUSSION
Asthma and obesity are growing public health
problems. Epidemiological data as well as data
from animal models implicate obesity as an im-
portant risk factor for asthma and atopic disease.
In this study, we studied the relationship between
adiponectin, leptin, and airway smooth muscle
cell proliferation. First, we demonstrated that
adiponectin receptors (AdipoR1 and AdipoR2)
were expressed in human ASM cells; to our
knowledge, this is the first report on such finding.
To evaluate the role of adiponectin and leptin in
the ASM cells, we stimulated ASM cells with adi-
ponectin and leptin, and found that adiponectin
and leptin did not directly influence human ASM
cell proliferation. However, since leptin increased
the release of VEGF from ASM cells, it must play
some role in asthma. Although ASM cells ex-
pressed adiponectin receptors, they did not
secrete adiponectin. It is, therefore, possible that
adiponectin plays a role through its receptors.
Since serum adiponectin declines in obesity and
adiponectin has an anti-inflammatory effect, these
anti-inflammatory effects might inhibit ASM cell
proliferation. Although adiponectin did not
suppress the proliferation of ASM cells, it
appeared to act on adiponectin receptors and
cause anti-allergic reactions. Indeed, some studies
have shown that adiponectin attenuated allergen-
induced airway inflammation and hyperrespon-
siveness in mice.
6,14
Leptin acts on the hypothalamus to induce
satiety and increase metabolism. In addition,
leptin has proinflammatory effects.
10 It has been
shown to protect T lymphocytes from apoptosis,
regulate T-cell proliferation and activation, recruit
and activate monocytes and macrophages, and
promote angiogenesis.
15 Given the facts that
serum leptin levels are increased in obesity and it
has proinflammatory effects, it is reasonable to
suggest that this hormone plays a role in asthma.
Leptin enhanced pulmonary inflammation
induced by acute ozone exposure and increased
AHR and serum IgE levels in mice.
3,5 On the other
hand, leptin has been shown to have no effect on
IL-13, IL-4 and IL-5 mRNA expressions in lung
tissue, and no direct effect on AHR in PBS-
challenged mice, while it has AHR in OVA-
challenged mice.
3 Leptin may be involved in
airway remodeling by inducing angiogenesis.
Leptin directly induces angiogenesis by activation
of its functional receptor, Ob-Rb, which is
expressed in endothelial cells.
16 In addition to its
angiogenic activity, leptin is also able to induce
vascular fenestrations and permeability.
17 Leptin
could indirectly induce angiogenesis via
upregulation of VEGF expression.
11,18 This fact is
consistent with our results that showed that leptin
induced VEGF release by ASM cells. VEGF is a
multifunctional angiogenic regulator that stimulates
subepithelial neovascularization and vascular
Fig. 5. Effect of PDGF, adiponectin and leptin on MCP-1
release by human ASM cells. Human ASM cells were
treated with PDGF (20 ng/mL), adiponectin (50 ng/mL),
and leptin (50 ng/mL). MCP-1 was constitutively released
from human ASM cells and was neither augmented by
PDGF or leptin stimulation, nor suppressed by adipo-
nectin. PDGF, platelet-derived growth factor; ASM,
airway smooth muscle.Adiponectin and Leptin on Smooth Muscle Cells
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permeability, a key finding in asthma. It also pro-
motes epithelial cell proliferation and endothelial
cell survival.
19,20 Recent data have shown that
VEGF also induces an asthma-like phenotype
characterized by mucus hyperplasia, subepithelial
fibrosis, smooth muscle hyperplasia, and AHR.
21-24
There has been no prior report on the
expression of leptin in ASM cells. Leptin mRNA
was detected in the lungs of mice.
3 In addition,
leptin expression has been found at sites of
wound healing and in inflamed colonic epithelial
cells.
25,26 Although we did not investigate the ASM
cell leptin receptor in this study, we can assume
that there are leptin receptors in ASM cells
because leptin augmented VEGF release by the
cultured ASM cells.
MCP-1 plays an important role in allergic
inflammation. MCP-1 expression is up-regulated
in asthmatic airways. Interestingly, it is also asso-
ciated with obesity. In obese mice, its expression
is augmented, and the adipose tissue inflamma-
tory gene expression is reduced in mice without
MCP-1 or MCP-1 receptors.
27,28 There is no prior
report demonstrating that leptin or adiponectin
affects MCP-1 release by ASM cells. In this study,
the release of MCP-1 by human ASM cells was not
influenced by adiponectin, leptin or PDGF. We
also evaluated whether ASM cells released
adiponectin and MIP-1 . However, neither was ɑ
detected in the cultured ASM cell supernatants
(data not shown). Since we stimulated ASM cells
only with leptin, adiponectin and PDGF and did
not investigate mRNA expression of adiponectin
and MIP-1 by RT-PCR, we do not know whether ɑ
adiponectin and MIP-1 are produced by ASM ɑ
cells. We did not investigate the effects of adipo-
nectin and leptin on the release of inflammatory
cytokines other than VEGF, MCP-1 and MIP-1 . ɑ
In conclusion, our results demonstrate for the first
time that adiponectin receptors (AdipoR1 and R2)
are expressed in human ASM cells. However,
adiponectin did not influence human ASM cell
proliferation or the release of VEGF and MCP-1.
Leptin promoted VEGF release by human ASM
cells, while it did not influence ASM cell pro-
liferation. Taken together, leptin and adiponectin
are not likely to be a therapeutic target for the
prevention of human ASM cell proliferation,
nevertheless leptin may modulate angiogenesis
and airway remodeling by promoting the release
of VEGF from ASM cells, and thus being a
potential therapeutic target in obese asthmatic
patients.
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